Literature DB >> 18191455

Effect of integrated treatment on the use of coercive measures in first-episode schizophrenia-spectrum disorder. A randomized clinical trial.

Johan Ohlenschlaeger1, Merete Nordentoft, Anne Thorup, Pia Jeppesen, Lone Petersen, Torben Ø Christensen, Gertrud Krarup, Per Jørgensen.   

Abstract

The effect of integrated treatment on the use of coercive measures in first-episode schizophrenia-spectrum disorder in Denmark is not known. A total of 328 patients were randomly assigned to integrated treatment (167 patients) or standard treatment (161 patients). Integrated treatment consisted of assertive community treatment, psycho-educational multi-family groups, and social skills training. Data on coercion were extracted from the register from the National Board of Health, and data on continuity from medical records. Even though the level of continuity seemed higher in integrated treatment, this did not reduce the use of coercive measures compared to the use in standard treatment.

Entities:  

Mesh:

Year:  2008        PMID: 18191455     DOI: 10.1016/j.ijlp.2007.11.003

Source DB:  PubMed          Journal:  Int J Law Psychiatry        ISSN: 0160-2527


  10 in total

Review 1.  Intensive case management for severe mental illness.

Authors:  Marina Dieterich; Claire B Irving; Bert Park; Max Marshall
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

2.  Impact of the creation and implementation of a clinical management guideline for personality disorders in reducing use of mechanical restraints in a psychiatric inpatient unit.

Authors:  Miguel Angel Gonzalez-Torres; Aranzazu Fernandez-Rivas; Sonia Bustamante; Fernando Rico-Vilademoros; Esther Vivanco; Karmele Martinez; Miguel Angel Vecino; Melba Martín; Sonia Herrera; Jorge Rodriguez; Carlos Saenz
Journal:  Prim Care Companion CNS Disord       Date:  2014-12-25

3.  The feasibility of cognitive adaptation training for outpatients with schizophrenia in integrated treatment.

Authors:  Jens Peter Hansen; Birte Østergaard; Merete Nordentoft; Lise Hounsgaard
Journal:  Community Ment Health J       Date:  2012-10-12

Review 4.  Intensive case management for severe mental illness.

Authors:  Marina Dieterich; Claire B Irving; Hanna Bergman; Mariam A Khokhar; Bert Park; Max Marshall
Journal:  Cochrane Database Syst Rev       Date:  2017-01-06

5.  Measures to Avoid Coercion in Psychiatry and Their Efficacy.

Authors:  Sophie Hirsch; Tilman Steinert
Journal:  Dtsch Arztebl Int       Date:  2019-05-10       Impact factor: 5.594

6.  Specialised early intervention teams for recent-onset psychosis.

Authors:  Stephen Puntis; Amedeo Minichino; Franco De Crescenzo; Andrea Cipriani; Belinda Lennox; Rachael Harrison
Journal:  Cochrane Database Syst Rev       Date:  2020-11-02

7.  Specialised early intervention teams (extended time) for recent-onset psychosis.

Authors:  Stephen Puntis; Amedeo Minichino; Franco De Crescenzo; Andrea Cipriani; Belinda Lennox; Rachael Harrison
Journal:  Cochrane Database Syst Rev       Date:  2020-11-02

8.  Psychosocial Interventions to Reduce Compulsory Psychiatric Admissions: A Rapid Evidence Synthesis.

Authors:  Jessica K Bone; Tayla McCloud; Hannah R Scott; Karen Machin; Sarah Markham; Karen Persaud; Sonia Johnson; Brynmor Lloyd-Evans
Journal:  EClinicalMedicine       Date:  2019-04-09

9.  Reduction of Involuntary Admissions in Patients With Severe Psychotic Disorders Treated in the ACCESS Integrated Care Model Including Therapeutic Assertive Community Treatment.

Authors:  Daniel Schöttle; Friederike Ruppelt; Benno G Schimmelmann; Anne Karow; Alexandra Bussopulos; Jürgen Gallinat; Klaus Wiedemann; Daniel Luedecke; Anja Christine Rohenkohl; Christian G Huber; Thomas Bock; Martin Lambert
Journal:  Front Psychiatry       Date:  2019-10-24       Impact factor: 4.157

10.  Can "Model Projects of Need-Adapted Care" Reduce Involuntary Hospital Treatment and the Use of Coercive Measures?

Authors:  Alexandre Wullschleger; Jürgen Berg; Felix Bermpohl; Christiane Montag
Journal:  Front Psychiatry       Date:  2018-05-01       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.